Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs
anthera.com

See what CB Insights has to offer

Founded Year

2004

Stage

PIPE | IPO

Total Raised

$55M

Market Cap

0.00B

Stock Price

0.04

About Anthera Pharmaceuticals

Anthera Pharmaceuticals is a pharmaceutical development company focused on the development and advancement of promising clinical products for the treatment of serious inflammatory diseases. Anthera's lead products have the potential to address a variety of inflammatory diseases including: acute lung injury, acute respiratory distress syndrome, acute chest syndrome, acute coronary syndrome, atherosclerosis, chronic obstructive pulmonary disease and psoriasis.

Anthera Pharmaceuticals Headquarter Location

25801 Industrial Boulevard Suite B

Hayward, California, 94545,

United States

510-856-5600

Latest Anthera Pharmaceuticals News

Impact Of Covid-19 On Atherosclerosis Market Demand and Future Scope With Top Key Players- Anthera Pharmaceuticals, Novartis AG, Sanofi, Johnson and Johnson, Bayer AG, The Medicine Company and Others

Jun 16, 2021

Search jobs 16-Jun-2021 Impact Of Covid-19 On Atherosclerosis Market Demand and Future Scope With Top Key Players- Anthera Pharmaceuticals, Novartis AG, Sanofi, Johnson and Johnson, Bayer AG, The Medicine Company and Others Atherosclerosis is the narrowing of the vein as a result of plaque build-up. Atherosclerosis is a particular kind of arteriosclerosis (stiffening or solidifying of the artery walls). The illness disturbs the stream of blood around the body, posturing genuine cardiovascular entanglements. Atherosclerosis begins when the endothelium gets to be harmed, permitting LDL cholesterol to aggregate in the artery wall. Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has causedsevere impacts on the global economy at various levels and which can be seen onthe Healthcare industry as well. The thriving market of health care researchand development is expected to exhibit a steep decline in the sales during thelockdown period owing to the shutdown of the manufacturing units, acuteshortage in the supply of raw materials and absence of potential manpower. Itcan be deduced from the current situations brought about by the pandemic thatthe production, and supply chain activities have experienced minor hurdles.However, the market is projected to gradually recover post-COVID-19, which willpresent attractive opportunities for sales across various regions of the worldin the following years. Future Market Insights (FMI) adopteda multidisciplinary approach during the pandemic-era to focus on the growth anddevelopment of the AtherosclerosisMarket . The study features insights on thecurrent growth dynamics and the major revenue reforms prevailing in the marketas along with the key takeaways over the forecast. The team of analysts at Future MarketInsights are focussing on research and market study to produce differentAtherosclerosis Market forecasts and predictions at both national andinternational levels. They have considered several leads of informationpertaining to the industry like market figures and merger estimations to assessand produce reliable and informative insights on the Atherosclerosis Market. To remain ‘ahead’ of your competitors, Ask aQuestion >> https://www.futuremarketinsights.com/ask-question/rep-gb-2523 Key Players The writer will create content on thegeneral strategies of market players. And then will write the key players inthe market are: GlaxoSmithKline plc., Merck & Co., Inc., F. Hoffmann-LaRoche Ltd., Isis Pharmaceuticals, Inc., Anthera Pharmaceuticals, Novartis AG, Sanofi,Johnson and Johnson, Bayer AG, The Medicine Company and Others Segmentation The report provides insights on the important highlights and currenttrends prevailing in the market. This helps the readers to gain a deeperunderstanding and form an unbiased opinion on the market. Numeroussegmentations have been provided for this market based on: ByTherapy Angioplasty Fullin-depth analysis of the parent market The analysts at FMI are dedicated toprovide insights after extensive research and study. The study also includesestimations, projections and evaluation of the market dynamics. Importantchanges in market dynamics The report has beencreated after detailed and exhaustive studies by the analysts at FMI takingseveral factors into consideration like monetary, ecological, social,mechanical, and political status of a particular demography. They study the keydata to assess the revenue and production of manufacturers across variousregions. The report also covers an in-depth analysis ofthe key changes in market dynamics in the recent past and the near future. Segmentationdetails of the market Emerging segments and regional markets Queries Solved What are the key segments andsub-segments in the market? What are the key drivers, restraints,opportunities, and challenges of the Atherosclerosis Market in the HealthcareIndustry, and how they are expected to impact the market? What are the attractive investmentopportunities within the Atherosclerosis Market in the Healthcare Industry? What is the Atherosclerosis Market inthe Healthcare Industry size at the regional and country-level? What are the key market playersfocusing on? What are the strategies for growthadopted by the key players in Atherosclerosis Market in the HealthcareIndustry? What are the recent trends inAtherosclerosis Market in the Healthcare Industry? (M&A, partnerships, newproduct developments, expansions)? What are the challenges to theAtherosclerosis Market in the growth of the Healthcare Industry? What are the key market trendsimpacting the growth of the Atherosclerosis Market in the Healthcare Industry? To receive extensive list of importantregions, ask for TOC here >>  https://www.futuremarketinsights.com/toc/rep-gb-2523 Table of Content MarketBackground    Reasons to Buythe report We provide authentic and detailed ananalysis on various market trends to enable businesses to make informed andbeneficial decisions to attain competitive edge over key players. Our analysts provide detailed marketsegmentation along with meaningful insights and extensive reports that othercompanies fail to include. The report includes accurate analysisof the market and the current developing trends affecting the growth. FMI speaks tostakeholders across the spectrum, including C-level executives, distributors,product manufacturers, industry experts. This ensures that the data collected is fromhighly reliable sources. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals,independent catheterization centers, and healthcare clinics will continuerising. Spurred by this, the global transradial closure devices market is setto grow by 6.5% CAGR during the forecast period from the year 2020 to 2030. In Vitro FertilizationBanking Services Market – The in vitro fertilization banking servicesmarket, despite undergoing a temporary period of lull due to COVID-19 outbreak,is likely to have an impressive growth trajectory between 2020 and 2030. Cryopreservationfor In-vitro Fertilization (IVF) Market – According to analysis by Future Market Insights (FMI), cryopreservationfor IVF market surpassed a valuation of US$ 339 million in 2019. Themarket is set to reflect an impressive 10.2% CAGR through 2030. About FMI        Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  is headquarteredin Dubai, the global financial capital, and has delivery centers in the U.S.and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Anthera Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Anthera Pharmaceuticals is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

R

Rare Diseases

229 items

B

Biopharmaceuticals

5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Anthera Pharmaceuticals Patents

Anthera Pharmaceuticals has filed 2 patents.

The 3 most popular patent topics include:

  • Autoimmune diseases
  • Clusters of differentiation
  • Kidney anatomy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/2/2008

11/1/2011

Hypolipidemic agents, Heart diseases, Lipid disorders, Cardiology, Vascular diseases

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/2/2008

00/00/0000

Grant Date

11/1/2011

00/00/0000

Title

Subscribe to see more

Related Topics

Hypolipidemic agents, Heart diseases, Lipid disorders, Cardiology, Vascular diseases

Subscribe to see more

Status

Grant

Subscribe to see more

Anthera Pharmaceuticals Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Anthera Pharmaceuticals Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.